Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. TIVC
TIVC logo

TIVC

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

TIVC News

Davis Commodities Reports $95M Revenue in H1, Up 42.1%

Dec 26 2025Benzinga

Tivic Grows Its Intellectual Property Assets

Nov 10 2025Newsfilter

Tivic Health Scheduled to Announce Third Quarter 2025 Financial Results on November 14th Through Conference Call and Webcast

Nov 06 2025Newsfilter

Tivic CEO Jennifer Ernst to Participate in Panel at Northwell Health Innovation Constellation Forum on October 23rd

Oct 22 2025Newsfilter

Live Stream Registration Now Open for Day 2 of the Emerging Growth Conference 86 on September 25

Sep 23 2025Globenewswire

Tivic Health's CEO Jennifer Ernst to Speak at Emerging Growth's Virtual Conference in September

Sep 22 2025Newsfilter

Tivic Finalizes Verification of Entolimod™ Cell Line: Initial Move Towards CGMP Manufacturing for BLA Submission

Sep 10 2025Newsfilter

Tivic Secures Two Investigational New Drug Applications for Entolimod™ Targeting Acute Radiation Syndrome (ARS) and Advanced Cancers

Aug 20 2025Newsfilter

Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025

Aug 15 2025Newsfilter

Stocks Moving Premarket: PMNT, KULR, ENLV, ORGN, And Other Gainers & Losers

Aug 15 2025NASDAQ.COM

Tivic Health (TIVC) Q2 2025 Earnings Transcript

Aug 14 2025NASDAQ.COM

Tivic Health Sales Drop 39 Percent

Aug 14 2025NASDAQ.COM

Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO

Jul 08 2025Newsfilter

Life Sciences Investor Forum: Now Available for Online Viewing

Jun 13 2025Newsfilter

Life Sciences Investor Forum Agenda Announced for June 11th-12th

Jun 10 2025Newsfilter

Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation

May 15 2025Newsfilter